ABSTRACT
BACKGROUND AND OBJECTIVE: Community-acquired pneumonia (CAP) is a frequent cause of hospitalisation. Several factors, such as pandemics, vaccines and globalisation may lead to changes in epidemiology, clinical presentation, and outcomes of CAP, which oblige to a constant actualisation. We performed this study to analyse how these factors have evolved over a 10-year period. MATERIALS AND METHODS: Patients diagnosed with CAP for two 1-year periods that were 10 years apart (2007-2008 and 2017-2018) were included. We compared microbiological information, clinical data and evolutive outcomes in the two periods. A mortality analysis was performed. RESULTS: 1043 patients were included: 452 during the first period (2007- 2008), and 591 during the second period (2017-2018). Bacterial aetiology did not change during the 10-year period, besides a slight increase in Staphylococcus aureus (0.9% vs 2.9%, p = 0.026). There was a decline in the proportion of bacteraemia in the second period (14.8% vs 9.6%, p = 0.012). The incidence of complicated pleural effusion and septic shock declined too (6.4% vs 3.6%, p = 0.04 and 15.5% vs 6.3%, p < 0.001). Respiratory failure and Intensive care unit (ICU) admission were similar in both periods. Variables independently associated with mortality were age and septic shock. Influenza vaccine was a protective factor against mortality in the second period. CONCLUSIONS: We have not found relevant differences in the bacterial aetiology of CAP over this 10-year period. There has been a decline in septic complications of CAP such as septic shock, bacteraemia, and complicated pleural effusion. Influenza vaccination is an important tool to reduce mortality.KEY MESSAGESThere were no differences in the bacterial pathogens causing CAP among the 10-year study period. There has been a decline in septic complications of CAP such as septic shock, bacteraemia, and complicated pleural effusion.
Subject(s)
Bacteremia , Community-Acquired Infections , Pleural Effusion , Pneumonia , Shock, Septic , Humans , Shock, Septic/complications , Community-Acquired Infections/epidemiology , Pneumonia/etiology , Pneumonia/complications , Pleural Effusion/complicationsABSTRACT
The performance of an immunofluorescence-based Streptococcus pneumoniae antigen detection test in pleural fluid (IF-PF) was evaluated. For proven and possible pneumococcal pneumonias global sensitivity and specificity were 92.6 (95 CI 76.6-97.9) and 80 (95 CI 62.7-90.5), respectively, with no significant differences between children and adults. Global diagnostic accuracy of IF-PF was 86% (74.2-93.7), and a substantial k index of concordance with culture/RT-PCR of 0.716 (0.535-0.896). IF-PF might be useful as a rapid complementary test for the etiologic diagnosis of pneumococcal pneumonia.
Subject(s)
Antigens, Bacterial/analysis , Bronchoalveolar Lavage Fluid/microbiology , Pneumonia, Pneumococcal/diagnosis , Streptococcus pneumoniae/immunology , Adolescent , Aged , Biosensing Techniques , Child , Child, Preschool , Female , Fluoroimmunoassay , Humans , Male , Middle Aged , Pleural Effusion/diagnosis , Pleural Effusion/microbiology , Retrospective Studies , Sensitivity and Specificity , Streptococcus pneumoniae/isolation & purificationABSTRACT
Bacterial vaginosis (BV) is the main cause of vaginal dysbacteriosis in the women during the reproductive age. It is an entity in which many studies have focused for years and which is still open for discussion topics. This is due to the diversity of microorganisms that cause it and therefore, its difficult treatment. Bacterial vaginosis is probably the result of vaginal colonization by complex bacterial communities, many of them non-cultivable and with interdependent metabolism where anaerobic populations most likely play an important role in its pathogenesis. The main symptoms are an increase of vaginal discharge and the unpleasant smell of it. It can lead to serious consequences for women, such as an increased risk of contracting sexually transmitted infections including human immunodeficiency virus and upper genital tract and pregnancy complications. Gram stain is the gold standard for microbiological diagnosis of BV, but can also be diagnosed using the Amsel clinical criteria. It should not be considered a sexually transmitted disease but it is highly related to sex. Recurrence is the main problem of medical treatment. Apart from BV, there are other dysbacteriosis less characterized like aerobic vaginitis of which further studies are coming slowly but are achieving more attention and consensus among specialists.
Subject(s)
Vaginosis, Bacterial/microbiology , Female , Humans , Pregnancy , Pregnancy Complications, Infectious/microbiology , Sexually Transmitted Diseases, Bacterial , Vaginal Discharge/microbiology , Vaginosis, Bacterial/complicationsABSTRACT
La vaginosis bacteriana (VB) es la principal causa de disbacteriosis vaginal de la mujer en edad reproductiva. Es una entidad en la que se centran numerosos estudios desde hace años y sobre la que sigue habiendo temas abiertos de debate. Esto se debe a la diversidad de microorganismos causantes y, por tanto, a su difícil tratamiento. La VB es el resultado de la colonización vaginal por comunidades bacterianas complejas, muchas de ellas no cultivables y con metabolismos interdependientes, donde las poblaciones anaerobias tienen muy probablemente un papel importante en su patogenia. Los principales síntomas son el aumento de la secreción vaginal y su desagradable olor. Puede comportar graves consecuencias para la mujer, como un mayor riesgo de contraer infecciones de transmisión sexual (ITS) incluyendo el virus de la inmunodeficiencia humana, así como complicaciones del tracto genital superior y durante el embarazo. La tinción de Gram es el método de referencia para el diagnóstico microbiológico de la VB, aunque también se puede diagnosticar aplicando los criterios clínicos de Amsel. No se debe considerar una ITS, sino una patología altamente relacionada con el sexo. La recidiva es el principal problema médico de su tratamiento. Además de la VB, existen otras disbacteriosis menos caracterizadas como la vaginitis aeróbica, de las que poco a poco van saliendo más estudios y sobre las que se va logrando una mayor atención y consenso entre especialistas
Bacterial vaginosis (BV) is the main cause of vaginal dysbacteriosis in the women during the reproductive age. It is an entity in which many studies have focused for years and which is still open for discussion topics. This is due to the diversity of microorganisms that cause it and therefore, its difficult treatment. Bacterial vaginosis is probably the result of vaginal colonization by complex bacterial communities, many of them non-cultivable and with interdependent metabolism where anaerobic populations most likely play an important role in its pathogenesis. The main symptoms are an increase of vaginal discharge and the unpleasant smell of it. It can lead to serious consequences for women, such as an increased risk of contracting sexually transmitted infections including human immunodeficiency virus and upper genital tract and pregnancy complications. Gram stain is the gold standard for microbiological diagnosis of BV, but can also be diagnosed using the Amsel clinical criteria. It should not be considered a sexually transmitted disease but it is highly related to sex. Recurrence is the main problem of medical treatment. Apart from BV, there are other dysbacteriosis less characterized like aerobic vaginitis of which further studies are coming slowly but are achieving more attention and consensus among specialists